AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3147895 — intervention group
Group type: COMPARATOR
Intervention: Transcutaneous oxygen pressure measurements
Number of subjects: 76
Study 31521153 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic technique
Number of subjects: 33
Study 31521153 — intervention group
Group type: COMPARATOR
Intervention: Microscopic technique
Number of subjects: 33
Study 28690703 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Thai massage
Number of subjects: 120
Study 28690703 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint mobilization
Number of subjects: 120
Study 25560821 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy protein-based meal replacements (S; n=12)
Number of subjects: 25
Study 25560821 — intervention group
Group type: COMPARATOR
Intervention: Non-soy protein-based meal replacements (NS; n=12)
Number of subjects: 25
Study 25560821 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined groups (S and NS)
Number of subjects: 25
Study 23815552 — intervention group
Group type: COMPARATOR
Intervention: Diskus (DK)
Number of subjects: 113
Study 23815552 — intervention group
Group type: EXPERIMENTAL
Intervention: Elpenhaler (EH)
Number of subjects: 113
Study 20036019 — intervention group
Group type: EXPERIMENTAL
Intervention: sugar‐free cocoa beverage
Number of subjects: 44
Study 20036019 — intervention group
Group type: EXPERIMENTAL
Intervention: sugar‐sweetened cocoa beverage
Number of subjects: 44
Study 20036019 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 44
Study 19478294 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (20 mg)
Number of subjects: 26
Study 19478294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 17109365 — intervention group
Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 186
Study 17109365 — intervention group
Group type: EXPERIMENTAL
Intervention: Locoregional Anesthesia (LA)
Number of subjects: 186
Study 15258452 — intervention group
Group type: COMPARATOR
Intervention: 3% ascorbic acid cream
Number of subjects: 25
Study 15258452 — intervention group
Group type: COMPARATOR
Intervention: sodium ascorbyl-2-phosphate
Number of subjects: 25
Study 11504009 — intervention group
Group type: EXPERIMENTAL
Intervention: Postevent questionnaire with manipulated overlap in narrative content, narrative structure, or environmental context
Number of subjects: 0
Study 11504009 — intervention group
Group type: COMPARATOR
Intervention: Control group with no specified intervention
Number of subjects: 0
Study 9076466 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative blood haemoglobin concentration in the range of 100-129 g/l
Number of subjects: 811
Study 9076466 — intervention group
Group type: EXPERIMENTAL
Intervention: Including 76 patients with a first AMI before surgery
Number of subjects: 811
Study 9076466 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted for impaired health status and age > or = 75 years, fluid absorption > or = 500 ml, and blood loss > or = 275 ml
Number of subjects: 811
Study 8419003 — intervention group
Group type: EXPERIMENTAL
Intervention: Indobufen (100 mg b.i.d.)
Number of subjects: 196
Study 8419003 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study 2939216 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketanserin
Number of subjects: 20
Study 2939216 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 20
Study 30716291 — intervention group
Group type: EXPERIMENTAL
Intervention: N2O-based cryoablation
Number of subjects: 60
Study 30716291 — intervention group
Group type: COMPARATOR
Intervention: Argon gas-based cryoablation
Number of subjects: 60
Study 29630023 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate insertion after D&E
Number of subjects: 120
Study 29630023 — intervention group
Group type: COMPARATOR
Intervention: Delayed insertion (2-4 weeks post-D&E)
Number of subjects: 120
Study 25756323 — intervention group
Group type: EXPERIMENTAL
Intervention: Incline treadmill running (INC) at 75%Vmax
Number of subjects: 12
Study 25756323 — intervention group
Group type: EXPERIMENTAL
Intervention: Incline treadmill running (INC) at 80%Vmax
Number of subjects: 12
Study 25756323 — intervention group
Group type: EXPERIMENTAL
Intervention: Incline treadmill running (INC) at 85%Vmax
Number of subjects: 12
Study 25756323 — intervention group
Group type: COMPARATOR
Intervention: Level-grade running at Vmax
Number of subjects: 12
Study 24442226 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnant period
Number of subjects: 2269
Study 24442226 — intervention group
Group type: COMPARATOR
Intervention: Nonpregnant period
Number of subjects: 2269
Study 24442226 — intervention group
Group type: COMPARATOR
Intervention: Postpartum period
Number of subjects: 2269
Study 23012594 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 168
Study 23012594 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID-only users
Number of subjects: 168
Study 23012594 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID use
Number of subjects: 168
Study 19567893 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 795
Study 19567893 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 795
Study 17519080 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg once daily
Number of subjects: 16
Study 15464786 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg) and Vitamin E (400 IU)
Number of subjects: 756
Study 15464786 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 756
Study 11488788 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 200
Study 11488788 — intervention group
Group type: COMPARATOR
Intervention: Milligan-Morgan haemorrhoidectomy
Number of subjects: 200
Study 7993133 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior management program
Number of subjects: 33
Study 7993133 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills program
Number of subjects: 33
Study 7993133 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 33
Study 3180198 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine
Number of subjects: 521
Study 3180198 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 521
Study 31937352 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/day krill oil
Number of subjects: 260
Study 31937352 — intervention group
Group type: COMPARATOR
Intervention: Inert placebo
Number of subjects: 260
Study 31699720 — intervention group
Group type: EXPERIMENTAL
Intervention: Foley catheter balloon (FCB)
Number of subjects: 100
Study 31699720 — intervention group
Group type: COMPARATOR
Intervention: Prostaglandin E2 (PGE2)
Number of subjects: 100
Study 28319122 — intervention group
Group type: EXPERIMENTAL
Intervention: PRONTO training (simulation and team-training program)
Number of subjects: 641
Study 26123096 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation patients (AF)
Number of subjects: 27
Study 26123096 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial fibrillation patients (AF) during AV pacing
Number of subjects: 27
Study 26123096 — intervention group
Group type: COMPARATOR
Intervention: Controls during AV pacing
Number of subjects: 27
Study 22970738 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin 0.1% eye drops
Number of subjects: 86
Study 22970738 — intervention group
Group type: COMPARATOR
Intervention: Ketorolac 0.5% eye drops
Number of subjects: 86
Study 21534021 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk-adapted dental care (RaDC)
Number of subjects: 800
Study 21534021 — intervention group
Group type: COMPARATOR
Intervention: Conventional dental care
Number of subjects: 800
Study 19927141 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise
Number of subjects: 0
Study 19927141 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-amount/moderate-intensity exercise
Number of subjects: 0
Study 19927141 — intervention group
Group type: COMPARATOR
Intervention: Low-amount/vigorous-intensity exercise
Number of subjects: 0
Study 19927141 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular walking exercise
Number of subjects: 0
Study 19927141 — intervention group
Group type: COMPARATOR
Intervention: Inactive individuals
Number of subjects: 0
Study 16500491 — intervention group
Group type: EXPERIMENTAL
Intervention: ivMCE (intravenous myocardial contrast echocardiography)
Number of subjects: 16
Study 12404073 — intervention group
Group type: EXPERIMENTAL
Intervention: Heroin (491 mg average daily dose, n=17)
Number of subjects: 33
Study 12404073 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine (597 mg average daily dose, n=16)
Number of subjects: 33
Study 10846637 — intervention group
Group type: EXPERIMENTAL
Intervention: Selected yoga practices (1 hr/session, morning and evening for 11 weeks)
Number of subjects: 33
Study 10846637 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment (drug intake every day for the whole experimental period)
Number of subjects: 33
Study 10846637 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 33
Study 9160923 — intervention group
Group type: EXPERIMENTAL
Intervention: ranitidine 300 mg twice daily for 2 weeks
Number of subjects: 117
Study 9160923 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 117
Study 8198040 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise (70% of heart rate reserve)
Number of subjects: 44
Study 8198040 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (80% to 85% of heart rate reserve)
Number of subjects: 44
Study 8198040 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 44
Study 2836189 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet (more carbohydrate)
Number of subjects: 6
Study 2836189 — intervention group
Group type: COMPARATOR
Intervention: Medium-fat diet (more sunflower oil)
Number of subjects: 6
Study 29704228 — intervention group
Group type: EXPERIMENTAL
Intervention: SG + TB
Number of subjects: 20
Study 29704228 — intervention group
Group type: COMPARATOR
Intervention: SMT
Number of subjects: 20
Study 26011772 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture
Number of subjects: 15
Study 26011772 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 15
Study 26011772 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 15
Study 26174114 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone furoate (FF) and umeclidinium (UMEC) 100/250 mcg
Number of subjects: 0
Study 26174114 — intervention group
Group type: COMPARATOR
Intervention: Umeclidinium (UMEC) as monotherapy
Number of subjects: 0
Study 24358760 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved central venous catheter indwelling of intraperitoneal drainage, irrigation, cavity injection, combined with systemic comprehensive treatment
Number of subjects: 54
Study 24358760 — intervention group
Group type: COMPARATOR
Intervention: Routine paracentesis
Number of subjects: 54
Study 24358760 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved central venous catheter indwelling
Number of subjects: 54
Study 21923249 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐IFN‐α 2b + RBV + ALC
Number of subjects: 60
Study 21923249 — intervention group
Group type: COMPARATOR
Intervention: Peg‐IFN‐α 2b + RBV
Number of subjects: 60
Study 18454096 — intervention group
Group type: EXPERIMENTAL
Intervention: Selank (30 patients)
Number of subjects: 62
Study 18454096 — intervention group
Group type: COMPARATOR
Intervention: Medazepam (32 patients)
Number of subjects: 62
Study 16816661 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction mammaplasty (surgery within 6 weeks)
Number of subjects: 73
Study 16816661 — intervention group
Group type: COMPARATOR
Intervention: Control group (surgery 6 months after recruitment)
Number of subjects: 73
Study 15018686 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluating current relationships against a romantic stereotype (Study 1)
Number of subjects: 0
Study 15018686 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluating alternative relationships against a high standard (Studies 2 and 3)
Number of subjects: 0
Study 15018686 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluating alternative relationships against a low standard (Studies 2 and 3)
Number of subjects: 0
Study 15018686 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived quality of alternatives
Number of subjects: 0
Study 11012133 — intervention group
Group type: EXPERIMENTAL
Intervention: Fetal pulse oximetry
Number of subjects: 0
Study 11012133 — intervention group
Group type: COMPARATOR
Intervention: Electronic fetal heart rate monitoring
Number of subjects: 0
Study 9108978 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II (Vasurfilcon A) contact lenses
Number of subjects: 20
Study 9108978 — intervention group
Group type: EXPERIMENTAL
Intervention: Group IV (Vifilcon A) contact lenses
Number of subjects: 20
Study 8498602 — intervention group
Group type: EXPERIMENTAL
Intervention: Low energy availability (8 kcal.kg body wt‐1.day‐1)
Number of subjects: 46
Study 8498602 — intervention group
Group type: COMPARATOR
Intervention: High energy availability (30 kcal.kg body wt‐1.day‐1)
Number of subjects: 46
Study 3104494 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 200 mg
Number of subjects: 59
Study 3104494 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 500 mg
Number of subjects: 59
Study 28632643 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace group
Number of subjects: 43
Study 28632643 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 43
Study 28038680 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate (MMF) for 2 years
Number of subjects: 142
Study 28038680 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cyclophosphamide (CYC) for 1 year followed by 1 year of placebo
Number of subjects: 142
Study 28038680 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 142
Study 24998644 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine-induced inflammation (typhoid vaccination)
Number of subjects: 18
Study 24998644 — intervention group
Group type: COMPARATOR
Intervention: Control (non-inflamed condition)
Number of subjects: 18
Study 22704742 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet support with a website for goal-setting and self-monitoring of weight and exercise plus minimal personal support
Number of subjects: 330
Study 22704742 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 330
Study 20526887 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-cm pillow
Number of subjects: 50
Study 20526887 — intervention group
Group type: COMPARATOR
Intervention: No pillow
Number of subjects: 50
Study 20526887 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-cm or 6-cm pillow
Number of subjects: 50
Study 19256282 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat, low-energy, lacto-ovo-vegetarian diet and exercise in a stress-free environment for one week
Number of subjects: 1349
Study 16183441 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 237
Study 16183441 — intervention group
Group type: COMPARATOR
Intervention: Standard Care (SCP)
Number of subjects: 237
Study 12794401 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine
Number of subjects: 20
Study 12794401 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 20
Study 12794401 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 20
Study 12794401 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine (severe shock)
Number of subjects: 20
Study 12794401 — intervention group
Group type: EXPERIMENTAL
Intervention: Norepinephrine (severe shock)
Number of subjects: 20
Study 11061767 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathway for inpatient asthma management
Number of subjects: 110
Study 11061767 — intervention group
Group type: COMPARATOR
Intervention: Conventional ward (control group)
Number of subjects: 110
Study 8840384 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplements
Number of subjects: 3939
Study 8840384 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-ingredient supplements
Number of subjects: 3939
Study 8840384 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic factors and access to health care
Number of subjects: 3939
Study 1621440 — intervention group
Group type: EXPERIMENTAL
Intervention: Horse chestnut seed extract
Number of subjects: 40
Study 1621440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 3912960 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 30 mg/day
Number of subjects: 12
Study 3912960 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 10 mg/day
Number of subjects: 12
Study 29847529 — intervention group
Group type: EXPERIMENTAL
Intervention: Battle Rope (BR) Training
Number of subjects: 30
Study 29847529 — intervention group
Group type: COMPARATOR
Intervention: Shuttle Run (SR) Training
Number of subjects: 30
Study 26350260 — intervention group
Group type: EXPERIMENTAL
Intervention: Subvastus approach (SVA)
Number of subjects: 50
Study 26350260 — intervention group
Group type: COMPARATOR
Intervention: Medial parapatellar approach (MPA)
Number of subjects: 50
Study 24811237 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Developmental Intervention (EDI)
Number of subjects: 376
Study 24811237 — intervention group
Group type: COMPARATOR
Intervention: Health Education Intervention (Control)
Number of subjects: 376
Study 22031508 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% long-chain triacylglycerols (LCT) emulsion
Number of subjects: 9
Study 22031508 — intervention group
Group type: EXPERIMENTAL
Intervention: 50/50% medium-chain triacylglycerols (MCT)/LCT emulsion
Number of subjects: 9
Study 22031508 — intervention group
Group type: COMPARATOR
Intervention: Glycerol
Number of subjects: 9
Study 20530096 — intervention group
Group type: COMPARATOR
Intervention: Non-penetrating control needle
Number of subjects: 10
Study 20530096 — intervention group
Group type: COMPARATOR
Intervention: Skin-touch placebo needle
Number of subjects: 10
Study 20530096 — intervention group
Group type: EXPERIMENTAL
Intervention: Penetrating needle
Number of subjects: 10
Study 18237683 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired myocardial perfusion (TMPG 0/1/2)
Number of subjects: 3491
Study 18237683 — intervention group
Group type: EXPERIMENTAL
Intervention: Restoration of normal epicardial flow (Thrombolysis In Myocardial Infarction flow grade 3) with impaired TMPG
Number of subjects: 3491
Study 18237683 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with left ventricular ejection fraction >or=30% and impaired TMPG
Number of subjects: 3491
Study 18237683 — intervention group
Group type: EXPERIMENTAL
Intervention: VT/VF occurrence
Number of subjects: 3491
Study 18237683 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with VT/VF and impaired TMPG
Number of subjects: 3491
Study 15955629 — intervention group
Group type: EXPERIMENTAL
Intervention: G2019S mutation testing in Parkinson's disease patients
Number of subjects: 1000
Study 15955629 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 1000
Study 12702130 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV‐1 rgp160 vaccine
Number of subjects: 30
Study 12702130 — intervention group
Group type: COMPARATOR
Intervention: Tetanus vaccine
Number of subjects: 30
Study 12702130 — intervention group
Group type: COMPARATOR
Intervention: No immunization
Number of subjects: 30
Study 12702130 — intervention group
Group type: COMPARATOR
Intervention: Tetanus vaccine (Control group)
Number of subjects: 30
Study 10233027 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol-17beta (1 mg micronized steroid twice daily orally)
Number of subjects: 9
Study 10233027 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 7546802 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I: Two or three cycles of cisplatin, vinblastine and mitomycin C
Number of subjects: 110
Study 7546802 — intervention group
Group type: EXPERIMENTAL
Intervention: Group II: Two cycles of cisplatin, VP16, alpha 1 timosine and interferon
Number of subjects: 110
Study 2007152 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led education program
Number of subjects: 82
Study 2007152 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult-led education program
Number of subjects: 82
Study 2007152 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 2007152 — intervention group
Group type: EXPERIMENTAL
Intervention: Satisfaction with providers
Number of subjects: 82
Study 6974543 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal splenorenal shunt
Number of subjects: 42
Study 6974543 — intervention group
Group type: COMPARATOR
Intervention: Central splenorenal shunt
Number of subjects: 42
Study 30737048 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based nutrition and physical activity intervention using IVAC methodology
Number of subjects: 0
Study 30737048 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 28024819 — intervention group
Group type: EXPERIMENTAL
Intervention: Lava C.O.S. CAD software and centralized CAM (group L)
Number of subjects: 10
Study 28024819 — intervention group
Group type: EXPERIMENTAL
Intervention: Cares CAD software and centralized CAM (group iT)
Number of subjects: 10
Study 28024819 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerec Connect CAD software and lab side CAM (group CiL)
Number of subjects: 10
Study 28024819 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerec Connect CAD software with centralized CAM (group CiD)
Number of subjects: 10
Study 28024819 — intervention group
Group type: COMPARATOR
Intervention: Conventional fabrication (group K)
Number of subjects: 10
Study 26538305 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 h sleep/night for five nights followed by one night with 12 h recovery sleep (experimental group)
Number of subjects: 47
Study 26538305 — intervention group
Group type: COMPARATOR
Intervention: 10 h sleep/night (control group)
Number of subjects: 47
Study 24308946 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis maintained for 12 months
Number of subjects: 50
Study 24308946 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis maintained for 24 months
Number of subjects: 50